The BRD4S-to-BRD4L switch was also seen at the protein level with both SPHINX31 and SRPK1 gRNA in all AML cells tested irrespective of MLL mutation status (Fig. 3g, Supplementary Fig. 8k–o). This evidence concerns the gene SRPK1 and acute myeloid leukemia.